Also, B cells mediated suppression of activated CD8+ T cells that kill tumor cells in NSCLC patients upon ICI treatment, may decrease with age, implying that B cells may play a pro-tumorigenic role in younger NSCLC patients [18]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.